425 related articles for article (PubMed ID: 10064160)
1. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
[TBL] [Abstract][Full Text] [Related]
2. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
3. Relation between alpha 1-adrenoceptor subtypes and noradrenaline-induced contraction in rat portal vein smooth muscle.
Sayet I; Neuilly G; Rakotoarisoa L; Mironneau C; Mironneau J
Br J Pharmacol; 1993 Sep; 110(1):207-12. PubMed ID: 8106102
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of alpha 1-adrenoceptor subtypes in rat heart: a binding study.
Noguchi H; Muraoka R; Kigoshi S; Muramatsu I
Br J Pharmacol; 1995 Mar; 114(5):1026-30. PubMed ID: 7780636
[TBL] [Abstract][Full Text] [Related]
5. Identification of alpha 1-adrenoceptor subtypes in the rabbit prostate.
Hiraoka Y; Ohmura T; Sakamoto S; Hayashi H; Muramatsu I
J Auton Pharmacol; 1995 Aug; 15(4):271-8. PubMed ID: 8576274
[TBL] [Abstract][Full Text] [Related]
6. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
Smith KM; Macmillan JB; McGrath JC
Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.
Nakamura S; Taniguchi T; Suzuki F; Akagi Y; Muramatsu I
Br J Pharmacol; 1999 Jul; 127(6):1367-74. PubMed ID: 10455286
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of alpha1-adrenoceptor subtypes in rat aorta and prostate.
Maruyama K; Suzuki M; Tsuchiya M; Makara Y; Hattori K; Ohnuki T; Watanabe K; Nagatomo T
Pharmacology; 1998 Aug; 57(2):88-95. PubMed ID: 9691228
[TBL] [Abstract][Full Text] [Related]
10. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
Muramatsu I; Taniguchi T; Okada K
Jpn J Pharmacol; 1998 Nov; 78(3):331-5. PubMed ID: 9869267
[TBL] [Abstract][Full Text] [Related]
11. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
12. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
[TBL] [Abstract][Full Text] [Related]
13. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.
Davis BJ; Wiener M; Chapple CR; Sellers DJ; Chess-Williams R
Auton Autacoid Pharmacol; 2015 Apr; 34(3-4):41-9. PubMed ID: 25790239
[TBL] [Abstract][Full Text] [Related]
14. Two distinct alpha 1-adrenoceptor subtypes in rabbit liver: a binding study.
Ohmura T; Muramatsu I
Br J Pharmacol; 1995 Nov; 116(6):2591-6. PubMed ID: 8590975
[TBL] [Abstract][Full Text] [Related]
15. Differential alpha1-adrenoceptor labeling by [3H]prazosin and [3H]tamsulosin.
Michel MC; Goepel M
Eur J Pharmacol; 1998 Jan; 342(1):85-92. PubMed ID: 9544796
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
Murata S; Taniguchi T; Muramatsu I
Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
[TBL] [Abstract][Full Text] [Related]
17. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
[TBL] [Abstract][Full Text] [Related]
18. α
Davis BJ; Chapple CR; Sellers DJ; Naylor AL; Sillar D; Campbell A; Chess-Williams R
J Pharmacol Sci; 2018 Aug; 137(4):366-371. PubMed ID: 30139713
[TBL] [Abstract][Full Text] [Related]
19. alpha(1L)-adrenoceptors mediate noradrenaline-induced contractions of the guinea-pig prostate stroma.
Pennefather JN; Lau WA; Chin C; Story ME; Ventura S
Eur J Pharmacol; 1999 Nov; 384(1):25-30. PubMed ID: 10611415
[TBL] [Abstract][Full Text] [Related]
20. Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
Maruyama K; Fukutomi J; Chiba T; Yamaguchi M; Takeda M; Hattori K; Nagatomo T
Gen Pharmacol; 1996 Dec; 27(8):1377-81. PubMed ID: 9304410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
